LFG
BMRN icon

Larson Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Larson Financial Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.1K Sell
596
-65
-10% -$3.56K ﹤0.01% 1708
2026
Q1 		$37.3K Buy
661
+98
+17% +$5.71K ﹤0.01% 1514
2025
Q4 		$33.5K Sell
563
-420
-43% -$22.9K ﹤0.01% 1434
2025
Q3 		$53.2K Sell
983
-416
-30% -$23.8K ﹤0.01% 1133
2025
Q2 		$76.9K Sell
1,399
-867
-38% -$51.1K ﹤0.01% 927
2025
Q1 		$160K Buy
2,266
+1,898
+516% +$128K 0.01% 671
2024
Q4 		$24.2K Buy
368
+190
+107% +$12.7K ﹤0.01% 1146
2024
Q3 		$12.5K Buy
178
+1
+0.6% +$84 ﹤0.01% 1385
2024
Q2 		$14.6K Hold
177
– – ﹤0.01% 1151
2024
Q1 		$15.5K Hold
177
– – ﹤0.01% 945
2023
Q4 		$17.1K Sell
177
-13
-7% -$1.15K ﹤0.01% 890
2023
Q3 		$16.8K Buy
190
+13
+7% +$1.16K ﹤0.01% 864
2023
Q2 		$15.3K Hold
177
– – ﹤0.01% 812
2023
Q1 		$17.2K Buy
177
+14
+9% +$1.45K ﹤0.01% 781
2022
Q4 		$16.9K Hold
163
– – ﹤0.01% 733
2022
Q3 		$14K Hold
163
– – ﹤0.01% 701
2022
Q2 		$14K Hold
163
– – ﹤0.01% 622
2022
Q1 		$13K Hold
163
– – ﹤0.01% 590
2021
Q4 		$14K Buy
+163
New +$13.4K ﹤0.01% 605

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Larson Financial Group's BMRN Position: Q2 2026 in Review

Larson Financial Group reduced its BioMarin Pharmaceuticals (BMRN) stake by 9.8% in Q2 2026, selling an estimated $3.56K and leaving 596 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Larson Financial Group first reported a position in BMRN in Q4 2021 and has held it in 19 quarters since. The position peaked at $160K in Q1 2025. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Larson Financial Group held 596 shares of BioMarin Pharmaceuticals worth $34.1K as of Q2 2026.
  • Larson Financial Group sold 65 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $3.56K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1708 holding.
  • Larson Financial Group first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Larson Financial Group's BioMarin Pharmaceuticals position peaked at $160K in Q1 2025.
  • 564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.